FY24 consensus $9.84. Raises FY24 operational revenue view to $89.4B-$89.8B from $89.2B-$89.6B, consensus $88.51B.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Notable companies reporting before tomorrow’s open
- Eli Lilly’s (NYSE:LLY) Crohn’s Disease Drug Outperforms JNJ’s Version
- Options Volatility and Implied Earnings Moves This Week, October 15 – October 18, 2024
- Johnson & Johnson (JNJ) Q3 Pre-Earnings: Here’s What to Expect
- Johnson & Johnson (JNJ) Q3 Earnings Cheat Sheet